-+ 0.00%
-+ 0.00%
-+ 0.00%

Edesa Biotech plans $3.5 million unregistered share sale in PIPE financing

PUBT·06/11/2026 13:15:13
Listen to the news
Edesa Biotech plans $3.5 million unregistered share sale in PIPE financing
  • Edesa Biotech priced a $3.5 million PIPE of common shares in an unregistered private placement.
  • Sold 729,241 common shares at USD 4.69 per share for investors; CEO subscribed at USD 5.21.
  • Financing was placed without an agent, underwriter, broker, or dealer; closing expected on or about June 15, 2026.
  • Proceeds earmarked to advance the vitiligo program, paridiprubart, working capital, general corporate purposes.
  • Plans to file a resale registration statement within 45 days of closing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edesa Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606110915PRIMZONEFULLFEED9735396) on June 11, 2026, and is solely responsible for the information contained therein.